Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study.
Schizophrenia is a multifactorial disease with changes in immunological system. Such changes are the result of cytokine-level disturbances connected with cytokine gene polymorphisms. However, research about cytokine gene polymorphisms in schizophrenia has been surprisingly limited and ambiguous. The aim of the study was to identify whether polymorphisms of interleukin (IL)-6 and IL-10 are risk factors for the development of paranoid schizophrenia in case-control study. IL-6 (-174G/C; rs 1800795) and IL-10 (-1082G/A; rs 1800896) promoter polymorphisms in patients with paranoid schizophrenia and healthy individuals were genotyped using polymerase chain reaction-restriction fragment length polymorphism method. Differences in IL-6 and IL-10 promoter haplotypes may play an important role in determining the transcription level for IL-6 and IL-10 genes in schizophrenic patients. The presence of allele C at position -174 of IL-6 promoter sequence may correlate with increasing risk of paranoid schizophrenia in the Polish population, but research on a broadened group of people is needed. The presence of allele G at position -1082 of IL-10 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population. The coexistence of genotype GG at position -1082 of IL-10 promoter sequence and genotype GC at position -174 of IL-6 promoter sequence correlates with increasing risk of paranoid schizophrenia in the Polish population.
Paul-Samojedny
Monika
M
Department of Medical Genetics, Medical University of Silesia, Ostrogorska 30, 41-200 Sosnowiec, Poland. mpaul@sum.edu.pl
Kowalczyk
Malgorzata
M
Suchanek
Renata
R
Owczarek
Aleksander
A
Fila-Danilow
Anna
A
Szczygiel
Aleksandra
A
Kowalski
Jan
J
D000328:Adult; D000483:Alleles; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics*; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011044:Poland / Q000453:epidemiology; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D012563:Schizophrenia, Paranoid / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology*
D015850:Interleukin-6; D016753:Interleukin-10
Mol Psychiatry. 1999 Jul;4(4):302-6
10483041
Lancet. 1997 Jan 18;349(9046):170-3
9111542
Ann Oncol. 2007 Aug;18(8):1376-81
17496310
J Biol Chem. 2000 Jun 16;275(24):18138-44
10747905
EMBO J. 1990 Jun;9(6):1897-906
2112087
Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1458-63
11557672
Eur Cytokine Netw. 2001 Mar;12(1):62-8
11282548
Acta Derm Venereol. 2008;88(2):113-6
18311435
J Neurosci. 1999 Jul 1;19(13):5236-44
10377335
Nat Genet. 2008 Jul;40(7):827-34
18583979
Eur Arch Psychiatry Clin Neurosci. 2008 Feb;258(1):10-5
17901998
Cytokine. 2009 Jul;47(1):1-5
19502081
Prog Neuropsychopharmacol Biol Psychiatry. 1998 Aug;22(6):947-57
9789879
Psychoneuroendocrinology. 2009 Apr;34(3):382-8
18990498
Hum Reprod. 2003 Feb;18(2):267-70
12571160
Eur Arch Psychiatry Clin Neurosci. 2005 Aug;255(4):279-83
15614591
Immunogenetics. 2002 Feb;53(10-11):851-6
11862386
J Rheumatol. 2006 Apr;33(4):703-8
16583473
Biol Psychiatry. 2002 Mar 15;51(6):480-4
11922883
Expert Rev Clin Immunol. 2005 May;1(1):103-12
20477658
Neurosci Lett. 2010 Jan 14;468(3):330-3
19914334
Schizophr Res. 2004 Nov 1;71(1):179-83
15374585
Eur Neuropsychopharmacol. 2000 Mar;10(2):119-24
10706993
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72
14642974
J Psychiatr Res. 2010 May;44(7):441-6
19939410
Clin Neurosci Res. 2006 Aug;6(1-2):52-68
18079991
Pharmacopsychiatry. 2006 Feb;39 Suppl 1:S68-71
16508900
Schizophr Bull. 1987;13(2):261-76
3616518
PLoS Genet. 2008 Feb;4(2):e28
18282107
Psychiatry Clin Neurosci. 2003 Apr;57(2):153-9
12667161
Neuropsychopharmacology. 2005 Aug;30(8):1532-8
15886721
Int J Neuropsychopharmacol. 2002 Jun;5(2):159-79
12135541
J Interferon Cytokine Res. 2000 Mar;20(3):291-8
10762076
Eur J Neurosci. 1993 Nov 1;5(11):1426-35
8287192
Psychiatry Clin Neurosci. 2009 Jun;63(3):257-65
19579286
Adv Protein Chem. 1998;52:223-51
9917922
Eur J Hum Genet. 2005 Jul;13(7):840-8
15827565
Neuropharmacology. 2009 Sep;57(3):193-200
19523965
Mol Psychiatry. 2007 Mar;12(3):273-82
17179997
J Med Genet. 2005 Mar;42(3):193-204
15744031
Psychiatry Clin Neurosci. 2007 Aug;61(4):364-9
17610660
J Med Virol. 2001 Nov;65(3):510-6
11596086
Curr Psychiatry Rep. 2007 Aug;9(4):329-36
17880866
World J Biol Psychiatry. 2009;10(4 Pt 2):461-8
19153889
Br J Psychiatry. 2007 Mar;190:194-9
17329737
Arthritis Res Ther. 2008;10(4):212
18771589
Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 4:62-8
10654111